Compare EYPT & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EYPT | AIV |
|---|---|---|
| Founded | 1987 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2005 | 1994 |
| Metric | EYPT | AIV |
|---|---|---|
| Price | $18.26 | $5.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $29.60 | $10.00 |
| AVG Volume (30 Days) | 1.3M | ★ 1.8M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 48.88% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.72 |
| Revenue | $42,339,000.00 | ★ $210,889,000.00 |
| Revenue This Year | N/A | $6.96 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.72 |
| Revenue Growth | N/A | ★ 39.67 |
| 52 Week Low | $3.91 | $5.24 |
| 52 Week High | $19.11 | $9.29 |
| Indicator | EYPT | AIV |
|---|---|---|
| Relative Strength Index (RSI) | 66.55 | 62.99 |
| Support Level | $16.52 | $5.53 |
| Resistance Level | $19.00 | $5.81 |
| Average True Range (ATR) | 1.04 | 0.11 |
| MACD | 0.10 | 0.04 |
| Stochastic Oscillator | 74.24 | 94.57 |
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development and Redevelopment; Operating, and Other. Development and Redevelopment segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. Operating segment includes 20 residential apartment communities with 5,243 apartment homes that have achieved a stabilized level of operations. Other segment includes The Benson Hotel, company's only hotel. Majority of revenue is gained from Operating Segment.